318 related articles for article (PubMed ID: 28852915)
1. Evaluation of Pharmacist-Initiated Interventions on Vaccination Rates in Patients with Asthma or COPD.
Klassing HM; Ruisinger JF; Prohaska ES; Melton BL
J Community Health; 2018 Apr; 43(2):297-303. PubMed ID: 28852915
[TBL] [Abstract][Full Text] [Related]
2. [Effect of influenza and 23-valent pneumococcal polysaccharide vaccinations on elderly with chronic obstructive pulmonary diseases: a community-based intervention study].
Wen Y; He L; Zhai Y; Wu J; Chen YY; Wang H; Zong QQ; Liang XF
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jun; 39(6):792-798. PubMed ID: 29936749
[No Abstract] [Full Text] [Related]
3. [The influence of influenza vaccination on asthma and chronic obstructive pulmonary disease].
Karwat KJ; Szpotańska M; Szulc Z; Chazan R
Pneumonol Alergol Pol; 2006; 74(1):80-3. PubMed ID: 17175983
[TBL] [Abstract][Full Text] [Related]
4. Pharmacists as providers: targeting pneumococcal vaccinations to high risk populations.
Taitel M; Cohen E; Duncan I; Pegus C
Vaccine; 2011 Oct; 29(45):8073-6. PubMed ID: 21864625
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the first pharmacist-administered vaccinations in Western Australia: a mixed-methods study.
Hattingh HL; Sim TF; Parsons R; Czarniak P; Vickery A; Ayadurai S
BMJ Open; 2016 Sep; 6(9):e011948. PubMed ID: 27650763
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Inpatient Influenza and Pneumococcal Vaccination Acceptance Rates With Pharmacist Education.
Queeno BV
J Pharm Pract; 2017 Apr; 30(2):202-208. PubMed ID: 26880320
[TBL] [Abstract][Full Text] [Related]
7. Use of Pneumococcal and influenza vaccine in patients with COPD, asthma bronchiale and interstitial lung diseases in south east Germany.
Mohr A; Plentz A; Sieroslawski A; Pezenburg F; Pfeifer M; Salzberger B; Hitzenbichler F
Respir Med; 2020; 174():106207. PubMed ID: 33152552
[TBL] [Abstract][Full Text] [Related]
8. Pharmacy patron perspectives of community pharmacist administered influenza vaccinations.
Alsabbagh MW; Church D; Wenger L; Papastergiou J; Raman-Wilms L; Schneider E; Waite N
Res Social Adm Pharm; 2019 Feb; 15(2):202-206. PubMed ID: 29724679
[TBL] [Abstract][Full Text] [Related]
9. A national examination of pharmacy-based immunization statutes and their association with influenza vaccinations and preventive health.
McConeghy KW; Wing C
Vaccine; 2016 Jun; 34(30):3463-8. PubMed ID: 27219340
[TBL] [Abstract][Full Text] [Related]
10. Costs of adult vaccination in medical settings and pharmacies: an observational study.
Singhal PK; Zhang D
J Manag Care Spec Pharm; 2014 Sep; 20(9):930-6. PubMed ID: 25166292
[TBL] [Abstract][Full Text] [Related]
11. Determinants of influenza and pneumococcal vaccination in patients with chronic lung diseases.
Schoefer Y; Schaberg T; Raspe H; Schaefer T
J Infect; 2007 Oct; 55(4):347-52. PubMed ID: 17681608
[TBL] [Abstract][Full Text] [Related]
12. Influenza vaccination for patients with chronic obstructive pulmonary disease: Implications for pharmacists.
Arabyat RM; Raisch DW; Bakhireva L
Res Social Adm Pharm; 2018 Feb; 14(2):162-169. PubMed ID: 28533080
[TBL] [Abstract][Full Text] [Related]
13. National survey of pharmacy-based immunization services.
Westrick SC; Patterson BJ; Kader MS; Rashid S; Buck PO; Rothholz MC
Vaccine; 2018 Sep; 36(37):5657-5664. PubMed ID: 30049631
[TBL] [Abstract][Full Text] [Related]
14. Impact of pneumococcal vaccination on pneumonia rates in patients with COPD and asthma.
Lee TA; Weaver FM; Weiss KB
J Gen Intern Med; 2007 Jan; 22(1):62-7. PubMed ID: 17351841
[TBL] [Abstract][Full Text] [Related]
15. [Pneumococcal vaccination rate in chronic obstructive pulmonary disease patients aged 40 years or older in China, 2014-2015].
Fan J; Cong S; Wang N; Lyu XL; Bao HL; Wang BH; Feng YJ; Yang T; Wang LH; Fang LW
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Jul; 41(7):1028-1033. PubMed ID: 32741165
[No Abstract] [Full Text] [Related]
16. Increasing adult vaccinations at a regional supermarket chain pharmacy: A multi-site demonstration project.
Coley KC; Gessler C; McGivney M; Richardson R; DeJames J; Berenbrok LA
Vaccine; 2020 May; 38(24):4044-4049. PubMed ID: 32093985
[TBL] [Abstract][Full Text] [Related]
17. Improving Influenza Vaccination Coverage Among Patients With COPD: A Pilot Project.
Li A; Chan YH; Liew MF; Pandey R; Phua J
Int J Chron Obstruct Pulmon Dis; 2019; 14():2527-2533. PubMed ID: 31814718
[TBL] [Abstract][Full Text] [Related]
18. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study.
Wongsurakiat P; Maranetra KN; Wasi C; Kositanont U; Dejsomritrutai W; Charoenratanakul S
Chest; 2004 Jun; 125(6):2011-20. PubMed ID: 15189916
[TBL] [Abstract][Full Text] [Related]
19. Interventions to Increase the Rate of Influenza and Pneumococcal Vaccination in Patients with Chronic Obstructive Pulmonary Disease: A Scoping Review.
Trethewey SP; Patel N; Turner AM
Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31208087
[No Abstract] [Full Text] [Related]
20. Generalist and subspecialist physicians' knowledge, attitudes, and practices regarding influenza and pneumococcal vaccinations for elderly and other high-risk patients: a nationwide survey.
Nichol KL; Zimmerman R
Arch Intern Med; 2001 Dec 10-24; 161(22):2702-8. PubMed ID: 11732935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
